Few years ago, we have demonstrated that AURKA and AURKB overexpression were associated with genomic instability in cytogenetically stratified group (Normal vs. Abnormal karyotype) of hematopoietic cells and bone marrow derived mesenchymal stem cells (MSCs) of myelodysplastic syndrome patients [42]. Here, AURKA is linked to myelodysplastic syndrome.